Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Strategies Targeting Amyloid-β in Alzheimer’s Disease
Lídia Pinheiro, Célia Faustino
Current Alzheimer Research (2019) Vol. 16, Iss. 5, pp. 418-452
Closed Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
Yong Peng, Hong Jin, Ya-hui Xue, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 69
Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer’s disease
Shan Ping Yu, Michael Qize Jiang, Seong S. Shim, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 58
Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis
Yue Qiao, Jian Gu, Miao Yu, et al.
CNS Drugs (2024) Vol. 38, Iss. 3, pp. 169-192
Closed Access | Times Cited: 17
Stem cell therapy for Alzheimer's disease
Xinyu Liu, Lin-Po Yang, Lan Zhao
World Journal of Stem Cells (2020) Vol. 12, Iss. 8, pp. 787-802
Open Access | Times Cited: 111
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
Daniela Liccardo, Federica Marzano, Federica Carraturo, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 89
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 15
Mechanisms and therapeutic potential of chinonin in nervous system diseases
Hui Zhang, Laifa Wang, Xueqin Wang, et al.
Journal of Asian Natural Products Research (2024) Vol. 26, Iss. 12, pp. 1405-1420
Closed Access | Times Cited: 13
Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers
Jaeyoon Song, E. Cho, H. -J. Lee, et al.
Biosensors (2025) Vol. 15, Iss. 2, pp. 102-102
Open Access | Times Cited: 1
Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia
Alisa Vollhardt, Lutz Froelich, Anna Stockbauer, et al.
Neurobiology of Disease (2025), pp. 106845-106845
Open Access | Times Cited: 1
Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups
Yue Zhang, Hongyuan Li, Sha Jin, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174829-174829
Closed Access | Times Cited: 38
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
Nidhi Puranik, Dhananjay Yadav, Minseok Song
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14044-14044
Open Access | Times Cited: 19
Signaling Pathways Involved in the Neuroprotective Effect of Osthole: Evidence and Mechanisms
Lovedeep Singh, Rajbir Bhatti
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 1100-1118
Closed Access | Times Cited: 18
Alzheimer’s Disease Immunotherapy: Current Strategies and Future Prospects
Ali Aljassabi, Tarek Zieneldien, Janice Kim, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 755-772
Closed Access | Times Cited: 6
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 6
Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
Carsten Esselun, Ellen Theyssen, Gunter P. Eckert
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8333-8333
Open Access | Times Cited: 40
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1897-1897
Open Access | Times Cited: 35
Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model
XiaoTong Xiang, Xin Wang, Yumei Wu, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 214, pp. 173340-173340
Closed Access | Times Cited: 26
On the microstructurally driven heterogeneous response of brain white matter to drug infusion pressure
Yuan Tian, Wenbo Zhan, Asad Jamal, et al.
Biomechanics and Modeling in Mechanobiology (2022) Vol. 21, Iss. 4, pp. 1299-1316
Open Access | Times Cited: 26
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1690-1720
Closed Access | Times Cited: 23
Alzheimer’s Disease “Non-amyloidogenic” p3 Peptide Revisited: A Case for Amyloid-α
Ariel J. Kuhn, Benjamin Abrams, Stella Knowlton, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1539-1544
Open Access | Times Cited: 33
Activation of the IL-17/TRAF6/NF-κB pathway is implicated in Aβ-induced neurotoxicity
Yulan Liu, Yang Meng, Chenliang Zhou, et al.
BMC Neuroscience (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 12
The relationship between protein modified folding molecular network and Alzheimer’s disease pathogenesis based on BAG2-HSC70-STUB1-MAPT expression patterns analysis
Xiaolong Yang, Wenbo Guo, Lin Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Precision medicines for the treatment of Alzheimer's disease
Sangameshwar B. Kanthale, Prakash N. Kendre, Somnath K. Vibhute, et al.
Elsevier eBooks (2024), pp. 253-263
Closed Access | Times Cited: 4
A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer’s mice
Khaled S. Abd‐Elrahman, Tash‐Lynn L. Colson, Shaarika Sarasija, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116388-116388
Open Access | Times Cited: 4
Sulfonic acid functionalized β-amyloid peptide aggregation inhibitors and antioxidant agents for the treatment of Alzheimer's disease: Combining machine learning, computational, in vitro and in vivo approaches
Vinit Raj, Chaitany Jayprakash Raorane, Divya Shastri, et al.
International Journal of Biological Macromolecules (2025), pp. 140142-140142
Closed Access
Page 1 - Next Page

Scroll to top